Total planned funding: $144,074,705
Allocations
Countries/Regions
Ukraine | $144,074,705 |
Organizational Types
Private Contractor | $35,293,894 |
NGO | $34,721,072 |
Unknown | $25,558,653 |
Own Agency | $20,754,655 |
Multi-lateral Agency | $11,125,607 |
University | $7,560,000 |
Implementing Agency | $5,000,000 |
Other USG Agency | $4,060,824 |
Program Areas
Governance and Systems | $57,530,572 |
Treatment | $32,875,007 |
Testing | $14,487,739 |
Prevention | $14,019,140 |
Management and Operations | $13,802,856 |
Care | $11,359,391 |
Budget Codes
OHSS: Health Systems Strengthening | $28,270,189 |
HTXS: Treatment: Adult Treatment | $21,336,836 |
HVSI: Strategic Information | $19,016,769 |
HVCT: Testing: HIV Testing and Counseling | $14,487,739 |
HVMS: Management and Operations | $13,802,856 |
HTXD: Treatment: ARV Drugs | $11,538,171 |
HLAB: Laboratory Infrastructure | $10,243,614 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $7,817,808 |
HVTB: Care: TB/HIV | $6,330,374 |
HVOP: Sexual Prevention: Other Sexual Prevention | $4,346,492 |
HBHC: Care: Adult Care and Support | $3,668,251 |
HMBL: Biomedical Prevention: Blood Safety | $1,778,944 |
HKID: Care: Orphans and Vulnerable Children | $1,360,766 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $75,896 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $0 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $0 |
PDTX: Treatment: Pediatric Treatment | $0 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
PDCS: Care: Pediatric Care and Support | $0 |
Top Partner Programs
Not Available:
$25,558,653
Countries/Regions
Chemonics International:
$20,772,383
Countries/Regions
USG Aggregated Agencies:
$18,439,068
Countries/Regions
Deloitte Consulting Limited:
$10,671,511
Countries/Regions